Modified feeding regimen for critically ill adults guided by a feeding-intolerance prediction model
Official title: Modifying Feeding Protocols for Critically Ill Patients (mNEED) Based on a Predictive Model of Feeding Intolerance in Critically Ill Patients: a Multicentre, Cohorts Randomized, Controlled Trial
Run by The First Hospital of Jilin University · NCT06827275 · Data updated 2026-11-12
This trial tests whether using a prediction model to guide enteral feeding schedules helps critically ill adult ICU patients tolerate and receive nutrition better.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 2250 (estimated) |
| Sponsor | The First Hospital of Jilin University Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 2 sites (Changchun, Jilin and 1 other locations) |
| Status | Recruiting |
| Started | February 25, 2025 |
| Main results expected | December 30, 2026 |
| Study ends | December 30, 2026 |
| Registry record updated | September 3, 2026 |
| Trial ID | NCT06827275 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (≥18 years) admitted to a participating ICU with organ dysfunction within 24 hours (SOFA ≥2), expected to stay >48 hours, unable to eat orally, and with no contraindication to enteral nutrition are ideal candidates.
✕Probably not a fit
Patients with severe gastrointestinal failure (AGI level IV), those who recently received enteral nutrition, those receiving palliative care with expected survival <48 hours, pregnant patients, or those on long-term immunosuppression or active chemo/radiotherapy are excluded and unlikely to benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
mNEED is a multicenter, cluster-randomized, controlled trial comparing a modified enteral feeding regimen guided by a feeding-intolerance prediction model to usual feeding practice in adult ICUs. ICUs (clusters) in Grade 2+ hospitals are randomized to apply the model-based feeding protocol or continue standard care, and eligible patients are adults with recent organ failure (SOFA ≥2), expected ICU stay >48 hours, unable to eat orally and without enteral nutrition contraindications. The intervention adjusts the enteral feeding process based on predicted risk of feeding intolerance, with outcomes focused on feeding tolerance, nutrition delivery, and clinical course during the ICU stay. Key exclusions include recent enteral nutrition within three days, AGI level IV, expected imminent death, pregnancy, long-term immunosuppression, active chemo/radiotherapy, or concurrent trial participation.
Why it matters
Potential benefit: If successful, the approach could reduce feeding intolerance and improve the amount of nutrition delivered to critically ill patients, which may lower complications and support recovery.
How similar studies have gone: Protocolized enteral feeding and some predictive tools have shown modest improvements in nutrition delivery and reduced intolerance in prior studies, but cluster-randomized trials using model-guided regimens are still limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Age 18 or older Failure of one or more organ systems within 24 hours of admission to the ICU (SOFA score ≥2) Expected to stay in ICU for more than 48 hours Inability to eat orally No EN taboo ICU Selection Criteria: ICU in Grade 2 or above hospitals ICU with the ability to carry out intensive care and monitor patient FI ICU type: emergency, medical, surgical, neurosurgical, or comprehensive ICU Exclusion Criteria: Patients who have received EN treatment in the past three days AGI Level IV patients Receiving palliative care and expected to die within 48 hours Pregnancy Long-term use of steroids or other immunosuppressants Patients undergoing radiotherapy or chemotherapy for malignant diseases Participation in other clinical studies ICU Exclusion Criteria: ICU that refuses to participate in the study ICU that has not passed the ethical review Pediatric ICU
Where it's running
-
The First Hospital of Jilin University
Changchun, Jilin, China Recruiting -
Jilin University, Chaoyang District, Changchun City, Jilin Province
Changchun, Jilin, China Not yet recruiting
Study contacts
- Study coordinator: Dong Zhang
- Email: zhangdong@jlu.edu.cn
- Phone: +86 155 8429 9391
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
ICU Delirium Playbook: Training for ICU Nurses
This program tests a multimedia training resource to help ICU nurses better screen for and manage delirium in critically ill patients.
-
Early Intervention After Sepsis-ICU to Reduce PTSD
This study tests whether an early psychiatric interview after discharge from the ICU for sepsis can help reduce PTSD and related symptoms.
-
Indirect calorimetry-guided nutrition in critically ill adults
This study tests whether using indirect calorimetry to guide how much energy ICU patients receive improves quality of life three months after ICU stay.
-
Helping preterm babies learn to feed using scheduled pacifier use
This study tests whether giving preterm babies a 5-minute pacifier before each feeding versus a 30-minute pacifier at random times helps them develop feeding skills faster and leave the hospital sooner.
-
Low-flow ECCO2R for ICU patients with respiratory failure: safety and outcomes
This review looks back at adults in the ICU who received low-flow ECCO2R to see if the treatment was safe and helped people with respiratory failure, including ARDS and severe asthma.
-
Using the Peripheral Perfusion Index to predict extubation success
This will test whether the Peripheral Perfusion Index (PPI) can help predict if adult ICU patients will be successfully extubated after a spontaneous breathing trial.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.